These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Statin therapy after acute ischemic stroke in the heart protection study: is the role in recurrent stroke prevention now defined? Coull BM Stroke; 2004 Sep; 35(9):2233-4. PubMed ID: 15272131 [No Abstract] [Full Text] [Related]
7. Ezetimibe and recent clinical trials: a look on the bright side. Ahmed MH Expert Opin Drug Saf; 2010 Jul; 9(4):511-4. PubMed ID: 20377476 [TBL] [Abstract][Full Text] [Related]
8. LDL-C goal attainment with the addition of ezetimibe to ongoing simvastatin treatment in coronary heart disease patients with hypercholesterolemia. Brohet C; Banai S; Alings AM; Massaad R; Davies MJ; Allen C Curr Med Res Opin; 2005 Apr; 21(4):571-8. PubMed ID: 15899106 [TBL] [Abstract][Full Text] [Related]
12. [The influence of ezetimibe and simvaststin on platelet aggregation and protein c system in patients with coronary heart disease and hypercholesterolemia]. Vashchenko VI; Kozobova AI; Filippov AE; Chechetkin AV; Popova NN; Vil'ianinov VN; Vashchenko TN Klin Med (Mosk); 2012; 90(3):66-8. PubMed ID: 22690571 [TBL] [Abstract][Full Text] [Related]
13. Clinical inquiries. What is the target for low-density lipoprotein cholesterol in patients with heart disease? Stevermer JJ; Meadows SE J Fam Pract; 2002 Oct; 51(10):893. PubMed ID: 12401164 [No Abstract] [Full Text] [Related]
14. Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease risk. Rosen JB; Ballantyne CM; Hsueh WA; Lin J; Shah AK; Lowe RS; Tershakovec AM Lipids Health Dis; 2015 Sep; 14():103. PubMed ID: 26336957 [TBL] [Abstract][Full Text] [Related]
15. Ezetimibe/simvastatin 10/20 mg versus simvastatin 40 mg in coronary heart disease patients. Averna M; Zaninelli A; Le Grazie C; Gensini GF J Clin Lipidol; 2010; 4(4):272-8. PubMed ID: 21122660 [TBL] [Abstract][Full Text] [Related]
16. The 4S study: a critical review. Pauciullo P Pharmacol Res; 1997 Mar; 35(3):165-6. PubMed ID: 9229401 [No Abstract] [Full Text] [Related]
17. Attaining United States and European guideline LDL-C levels with simvastatin in patients with coronary heart disease (the GOALLS study). Mikhailidis DP; Wierzbicki AS Curr Med Res Opin; 2000; 16(3):205-7. PubMed ID: 11191011 [No Abstract] [Full Text] [Related]
18. Replication of the Scandinavian Simvastatin Survival Study using a primary care medical record database prompted exploration of a new method to address unmeasured confounding. Weiner MG; Xie D; Tannen RL Pharmacoepidemiol Drug Saf; 2008 Jul; 17(7):661-70. PubMed ID: 18327857 [TBL] [Abstract][Full Text] [Related]
19. Comments on the MRC/BHF Heart Protection Study. Mikhail N Lancet; 2003 Aug; 362(9385):744; author reply 744-5. PubMed ID: 12957101 [No Abstract] [Full Text] [Related]